18
Participants
Start Date
April 30, 2009
Primary Completion Date
July 31, 2011
Study Completion Date
March 31, 2012
BPX-101
Vaccine
AP1903
Activating agent, infusion
University of Texas Health Science Center Houston, CRU, Houston
Lead Sponsor
M.D. Anderson Cancer Center
OTHER
The University of Texas Health Science Center, Houston
OTHER
Memorial Hermann Hospital
OTHER
Baylor College of Medicine
OTHER
Bellicum Pharmaceuticals
INDUSTRY